stockrowCollegium Pharmaceutical, Inc. (COLL) vs Alpha Teknova, Inc. (TKNO)
- Collegium Pharmaceutical, Inc. COLL 25.07 +5.91%
- Alpha Teknova, Inc. TKNO 7.83 +6.24%
Collegium Pharmaceutical, Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $819.1M against $486.2M — 1.7× the size. Alpha Teknova, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 20.5×. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 15.5% against 7.68%. Collegium Pharmaceutical, Inc. has the higher net margin (4.68% vs −34.8%) and the higher return on invested capital (5.63% vs −16.6%). Across the 19 metrics below, Collegium Pharmaceutical, Inc. leads on 13 and Alpha Teknova, Inc. on 6.
Valuation
Profitability
| Metric | COLL | TKNO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 59.05% | 36.43% | 53.51% |
| Operating margin | 15.22% | (32.65%) | 0.00% |
| Net margin | 4.68% | (34.76%) | (2.45%) |
| Free cash flow margin | 41.25% | (13.89%) | 0.00% |
| Return on equity | 13.36% | (24.12%) | (0.80%) |
| Return on assets | 2.06% | (15.79%) | (1.67%) |
| Return on invested capital | 5.63% | (16.60%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack